Drug Profile
P 321
Alternative Names: P-321; SHP-659; TAK-759Latest Information Update: 14 Jul 2021
Price :
$50
*
At a glance
- Originator Parion Sciences
- Class Eye disorder therapies; Small molecules
- Mechanism of Action Epithelial sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dry eyes